Cargando…
HBV pgRNA profiles in Chinese HIV/HBV coinfected patients under pre‐ and posttreatment: a multicentre observational cohort study
Data on hepatitis B virus (HBV) pregenomic (pgRNA) levels in HIV/HBV coinfected patients pre‐ and post‐combined antiretroviral therapy (cART) are limited. This study aimed to evaluate the distribution of HBV pgRNA levels in treatment‐naive coinfected patients and explore the changes that occur after...
Autores principales: | Xu, Ling, Li, Xiaodi, Lu, Lianfeng, Liu, Xiaosheng, Song, Xiaojing, Li, Yanling, Han, Yang, Zhu, Ting, Cao, Wei, Li, Taisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541493/ https://www.ncbi.nlm.nih.gov/pubmed/35582838 http://dx.doi.org/10.1111/jvh.13704 |
Ejemplares similares
-
Measuring hepatitis B pgRNA stability using an updated automated HBV pgRNA assay with increased sensitivity
por: Anderson, Mark, et al.
Publicado: (2023) -
RNA binding protein TIAR modulates HBV replication by tipping the balance of pgRNA translation
por: Zhang, Ting, et al.
Publicado: (2023) -
TRIM25 inhibits HBV replication by promoting HBx degradation and the RIG-I-mediated pgRNA recognition
por: Song, Hongxiao, et al.
Publicado: (2023) -
Saikosaponin C exerts anti-HBV effects by attenuating HNF1α and HNF4α expression to suppress HBV pgRNA synthesis
por: Pan, Yanchao, et al.
Publicado: (2019) -
CD4(+) T cell counts and soluble programmed death-1 at baseline correlated with hepatitis B surface antigen decline in HIV/HBV coinfection during combined antiretroviral therapy
por: Li, Xiaodi, et al.
Publicado: (2023)